N
ACLX

Nuveen’s Arcellx ACLX Stock Holding History

Nuveen’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.79M Buy
85,294
+3,350
+4% +$296K ﹤0.01% 1567
2025
Q4 		$5.34M Sell
81,944
-1,483
-2% -$118K ﹤0.01% 1882
2025
Q3 		$6.85M Sell
83,427
-3,991
-5% -$287K ﹤0.01% 1754
2025
Q2 		$5.76M Sell
87,418
-24,368
-22% -$1.52M ﹤0.01% 1810
2025
Q1 		$7.33M Hold
111,786
– – ﹤0.01% 1724
2024
Q4 		$8.57M Sell
111,786
-9,110
-8% -$787K ﹤0.01% 1673
2024
Q3 		$10.1M Sell
120,896
-1,015
-0.8% -$67.6K ﹤0.01% 1598
2024
Q2 		$6.73M Sell
121,911
-64,872
-35% -$3.53M ﹤0.01% 1796
2024
Q1 		$13M Sell
186,783
-92,843
-33% -$5.89M ﹤0.01% 1449
2023
Q4 		$15.5M Buy
279,626
+35,433
+15% +$1.6M 0.01% 1323
2023
Q3 		$8.76M Buy
244,193
+7,127
+3% +$246K ﹤0.01% 1563
2023
Q2 		$7.5M Buy
237,066
+138,577
+141% +$5.3M ﹤0.01% 1675
2023
Q1 		$3.03M Buy
98,489
+8,686
+10% +$263K ﹤0.01% 2162
2022
Q4 		$2.78M Sell
89,803
-14,315
-14% -$328K ﹤0.01% 2239
2022
Q3 		$1.95M Buy
104,118
+91,236
+708% +$1.75M ﹤0.01% 2414
2022
Q2 		$233K Buy
12,882
+171
+1% +$2.21K ﹤0.01% 3135
2022
Q1 		$178K Buy
+12,711
New +$213K ﹤0.01% 3206

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Nuveen's ACLX Position: Q1 2026 in Review

Nuveen increased its Arcellx (ACLX) stake by 4.1% in Q1 2026, buying an estimated $296K and bringing the position to 85,294 shares worth $9.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1567.

Nuveen first reported a position in ACLX in Q1 2022 and has held it in 17 quarters since. The position peaked at $15.5M in Q4 2023. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Nuveen held 85,294 shares of Arcellx worth $9.79M as of Q1 2026.
  • Nuveen bought 3,350 Arcellx shares in Q1 2026, an estimated $296K.
  • Arcellx made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #1567 holding.
  • Nuveen first reported a position in Arcellx in Q1 2022 and has held it in 17 quarters since.
  • Nuveen's Arcellx position peaked at $15.5M in Q4 2023.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.